Publications by authors named "Helena Colom Codina"

Claim this Profile
O
Optimising Meropenem and Piperacillin Dosing in Patients Undergoing Extracorporeal Membrane Oxygenation Without Renal Dysfunction (MEPIMEX).
Mar Ronda, M Paz Fuset, Erika Esteve-Pitarch, Josep Llop, Victor Daniel Gumucio-Sanguino, Helena Colom-Codina

Antibiotics (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alginate Hydrogel Formulation with Ketorolac for the Treatment of Pain Related Sialolithiasis.
Cristina Silva, Gladys Ramos-Yacasi, Mireia Mallandrich, Helena Colom-Codina, Joaquim Suñer-Carbó

Gels· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients.
Javier Martínez-Casanova, Erika Esteve-Pitarch, Helena Colom-Codina, Víctor Daniel Gumucio-Sanguino, Sara Cobo-Sacristán

Antibiotics (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure?
Erika Esteve-Pitarch, Víctor Daniel Gumucio-Sanguino, Sara Cobo-Sacristán, Evelyn Shaw, Kristel Maisterra-Santos, Helena Colom-Codina

Eur J Drug Metab Pharmacokinet· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayes-based dosing of infliximab in inflammatory bowel diseases: Short-term efficacy.
Eugènia Santacana Juncosa, Lorena Rodríguez-Alonso, Ariadna Padullés Zamora, Jordi Guardiola, Francisco Rodríguez-Moranta, Helena Colom Codina

Br J Clin Pharmacol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion.
Erika Esteve-Pitarch, Ariadna Padullés-Zamora, Kristel Maisterra-Santos, Helena Colom-Codina, Sara Cobo-Sacristán

Farm Hosp· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of infliximab population pharmacokinetic model for dose optimization in ulcerative colitis patients.
Eugènia Santacana Juncosa, Ariadna Padullés Zamora, Helena Colom Codina, Lorena Rodríguez Alonso, Jordi Guardiola Capo

Rev Esp Enferm Dig· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semimechanistic model to characterize nonlinear pharmacokinetics of nimotuzumab in patients with advanced breast cancer.
Leyanis Rodríguez-Vera, Mayra Ramos-Suzarte, Eduardo Fernández-Sánchez, Jorge Luis Soriano, Concepción Peraire Guitart, Helena Colom Codina

J Clin Pharmacol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Individualized infliximab therapy: pharmacokinetic monitoring].
Eugènia Santacana-Juncosa, Ariadna Padullés-Zamora, Helena Colom Codina, Lorena Rodríguez-Alonso, Jordi Guardiola-Capon

Farm Hosp· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis